Evidence map›Paper›PMID 24500710›Full record

ArticleThe Journal of biological chemistry2014

Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2.

Courtney E Sparacino-Watkins, Jesús Tejero, Bin Sun, Marc C Gauthier, John Thomas, Venkata Ragireddy, Bonnie A Merchant, Jun Wang, Ivan Azarov, Partha Basu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Structure and function of periplasmic nitrate reductase.Biochemical Society transactions · 2026
    Review
  4. Bovine xanthine oxidase electrocatalysis: substrate oxidation and its role in nitrite reduction.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  5. Review
  6. Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Courtney E Sparacino-WatkinsVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
Jesús TejeroVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Bin SunVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
Marc C GauthierVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
John ThomasDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282.
Venkata RagireddyVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Bonnie A MerchantVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Jun WangVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Ivan AzarovVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Partha BasuDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282.
Mark T GladwinVascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213. Electronic address: gladwinmt@upmc.edu.
University of Pittsburgh · USDuquesne University · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
Translational Training Program in Pulmonary Biology and MedicineT32HL007563 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Koenigshoff · 1985 to 2026
$12.3M
Myoglobin as a Nitrite Reductase that Regulates Hypoxic Cardiac NO SignalingR01HL096973 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T, SHIVA, SRUTI · 2010 to 2013
$1.5M
Dietary nitrate activation of PPARgamma improves insulin sensitivityRC1DK085852 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN, GLADWIN, MARK T · 2009 to 2010
$999k
NHLBI NIH HHS HL096973NHLBI NIH HHS HL098032NHLBI NIH HHS P01 HL103455NHLBI NIH HHS R01 HL096973NHLBI NIH HHS R01 HL098032NHLBI NIH HHS T32 HL007563NIDDK NIH HHS DK085852NIDDK NIH HHS RC1 DK085852
6 · The paper itself

Abstract

Mitochondrial amidoxime reducing component (mARC) proteins are molybdopterin-containing enzymes of unclear physiological function. Both human isoforms mARC-1 and mARC-2 are able to catalyze the reduction of nitrite when they are in the reduced form. Moreover, our results indicate that mARC can generate nitric oxide (NO) from nitrite when forming an electron transfer chain with NADH, cytochrome b5, and NADH-dependent cytochrome b5 reductase. The rate of NO formation increases almost 3-fold when pH was lowered from 7.5 to 6.5. To determine if nitrite reduction is catalyzed by molybdenum in the active site of mARC-1, we mutated the putative active site cysteine residue (Cys-273), known to coordinate molybdenum binding. NO formation was abolished by the C273A mutation in mARC-1. Supplementation of transformed Escherichia coli with tungsten facilitated the replacement of molybdenum in recombinant mARC-1 and abolished NO formation. Therefore, we conclude that human mARC-1 and mARC-2 are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor. Finally, expression of mARC-1 in HEK cells using a lentivirus vector was used to confirm cellular nitrite reduction to NO. A comparison of NO formation profiles between mARC and xanthine oxidase reveals similar Kcat and Vmax values but more sustained NO formation from mARC, possibly because it is not vulnerable to autoinhibition via molybdenum desulfuration. The reduction of nitrite by mARC in the mitochondria may represent a new signaling pathway for NADH-dependent hypoxic NO production.

Indexed as

Amino Acid SequenceCoenzymesCytochrome ReductasesCytochromes b5Electron TransportHEK293 CellsHumansHydrogen-Ion ConcentrationKineticsMetalloproteinsMitochondriaMitochondrial ProteinsMolecular Sequence DataMolybdenumMolybdenum CofactorsNitric OxideCoenzymesCytochrome ReductasesCytochromes b5Metalloproteinsmitochondrial amidoxime reducing component 2, humanMitochondrial ProteinsMolybdenumMolybdenum CofactorsmolybdopterinMTARC1 protein, humanNitric OxideNitric Oxide SynthaseNitrite ReductasesNitritesOxidoreductasesOxygenPteridinesRecombinant ProteinsXanthine OxidaseHypoxiaMitochondriaMolybdenumNitric OxideReductaseVascular Biology

Identifiers

PMID24500710
PMCPMC4036158
OpenAlexW2068477954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.